Abstract
Objective Functional MRI (fMRI) is sensitive to changes in the blood oxygen level-dependent (BOLD) signal, which originates from neurovascular coupling, the mechanism that links neuronal activity to changes in cerebral blood flow. Isolating the native spontaneous neuronal fluctuations from the BOLD signal of the resting-state is challenging, as the signal induced by neuronal activity represents only a small part of this signal. Furthermore, many other non-neuronal (systemic) oscillations contribute, such as from the cardiovascular and respiratory system with frequencies partly overlapping those of the spontaneous fluctuations. The objective of this study is to investigate to what extent various systemic physiological signals are associated with the measured BOLD signal, in particular the frequency interval pertaining to the spontaneous cerebral fluctuations (10-100 mHz). Additionally, we investigate whether these associations were independent of cardiometabolic risk factors.
Methods Within the population-based Maastricht Study, 3T resting-state functional MRI and physiological measures, covering cardiac, respiratory, myogenic, neurogenic, and endothelial activity, were acquired (n=1,651, 48% woman, aged 59±8 years). As both neuronal and non-neuronal physiological signals contain frequencies that vary over time, a wavelet transformation (WT) was used. Time-series were decomposed into seven wavelet subbands, and for each subband, the energy of the BOLD signal was calculated. Multivariable linear regression analysis was used to investigate the association of the physiological measures, in particular cognitive function, with the wavelet energy per subband, independent of cardiometabolic risk factors.
Results We found that physiological measures were associated with the energy of certain frequency subbands of the spectrum of the measured fMRI signal. Both cognitive performance and blood pressure variations, as measures of neurogenic and myogenic activity respectively, were associated with the energy of the frequency subband 3 (31.2-62.5 mHz). Furthermore, cardiac and respiratory activity were associated with the energy of the high frequency subband 1 (>125 mHz), and endothelial activity with the energy of low frequency subbands 6 and 7 (<10 mHz). Part of these associations were dependent on cardiometabolic risk factors.
Conclusion We found an association between myogenic and neurogenic activity and the frequency specific BOLD signal. Our findings highlight the strong intertwining of neuronal, vascular, and cardiometabolic activity and emphasize the importance of a proper selection of the resting-state frequency range in fMRI studies on cognitive function.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands), NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands), School for Mental Health & Neuroscience (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human participants were approved by the institutional Medical Ethical Committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). All participants gave written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon a reasonable request to management of the Maastricht Study (research.dms{at}mumc.nl)
